Every hour of every day in hospital, different type and levels of anaesthesia are executed and lives are being saved in intensive care unit. The anaesthesiologist play an important role in this complex environment conducting the patient along the clinical pathway from admission to discharge.
Our exceptional portfolio provide reliable solutions to support the anaesthesiologist in the choice and combination of medication, dose, route and techniques, considering the risks and benefits for the individual patient to improve the clinical experience for patient and organization.
Quality And Predictability Of Recovery
An effective use of anaesthetic administration may allow faster recovery and can improve patient satisfaction. The combination of short-acting opioids and hypnotic given exclusively by the intravenous route, TIVA, offers several potential advantages compare with inhalational anaesthesia.    
These include reduced incidence of post-operative nausea and vomiting, greater hemodynamic more predictable and rapid recovery with a reduced atmospheric pollution.  ; Recent articles address the fact that TIVA can reduce the incidence of Post-Operative Delirium and the risk of recurrence in cancer surgery  
Pain Control And Enhanced Operational Efficiencies
Adequate pain management along with anaesthesia is crucial for medical and surgical procedures as well as during the post-operative phase.
General anaesthesia can be replaced by combinations of regional and local methods such as regional nerve blocks, neuraxial anaesthesia (spinal / epidural approach), or direct local infiltration. 
Some anaesthesia solutions are also available in several topical formulation like cream, gel, spray or patch to help caregivers to improve the comfort of the patients and his family in everyday life.
Formulations Designed To Improve Patient Safety
All the Patient Safety organization have the mission to improve the safety of patients during anaesthesia care by encouraging safety research, education and distributing clear recommendations.  
ESA, APSF and EBA association recommended the use of standardized, premixed, ready-to- use formulation to reduce the risks of errors. They all recognized that the inclusion of pre-filled syringes for anaesthesiology medication delivery has the potential to improve medication safety .    
Extrinsic contamination of anaesthetic agents has been identified as one of the risk factors for healthcare-associated infection and clinical articles suggested to use intravenous anaesthetics with EDTA formulation and the use of prefilled syringes to reduce the risk of contamination while drawing up the drug.   
Whether the anaesthesiologist will decide to conduct intravenous anaesthesia, sedation or local/regional anaesthesia Aspen can provide a comprehensive portfolio of drugs to support him along the whole clinical pathway.
* Group’s acquisition of the rights to commercialise anaesthesia product portfolio worldwide except in the USA.
-  British Journal of Anaesthesia 114 (4): 663–8 (2015)
Type of anaesthesia and patient quality of recovery: a randomized trial comparing propofol–remifentanil tota i.v. anaesthesia with desflurane anaesthesia
W.-K. Lee1, M.-S. Kim1, S.-W. Kang2, S. Kim1 and J.-R. Lee1*
-  Anaesthesist
1999 · 48:807–812 © Springer-Verlag 1999S
TIVA mit Propofol/Remifentanil oder balancierte AnästhesiE mit Sevofluran/Fentanyl bei laparoskopischen Operationen
. Juckenhöfel1 · C. Feisel2 · H.J. Schmitt2 · A. Biedler1
-  Anesthesiology 2016; 124:69-79
Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery A Retrospective Analysis
Timothy J. Wigmore, M.A., F.R.C.A., F.F.I.C.M., F.C.I.C.M., Kabir Mohammed, M.Sc.,
Shaman Jhanji, Ph.D., M.R.C.P., F.R.C.A., F.F.I.C.M.
-  Springer International Publishing AG 2017
Advantages, Disadvantages, and Risks of TIVA/TCI ;Ken B. Johnson
A.R. Absalom, K.P. Mason (eds.), Total Intravenous Anesthesia and Target Controlled Infusions, DOI 10.1007/978-3-319-47609-4_32 621
-  Target-Controlled Infusion: A Mature Technology
Anthony R. Absalom, MBChB, FRCA, MD,* John (Iain) B. Glen, BVMS, PhD, FRCA,† Gerrit J. C. Zwart, MD,*Thomas W.
-  Anesthesiology 2014; 120:703-13
Ultrasound-guided Multilevel Paravertebral Blocks and Total Intravenous Anesthesia Improve the Quality of Recovery after Ambulatory Breast Tumor Resection
Faraj W. Abdallah, M.D., Pamela J. Morgan, M.D., F.R.C.P.C., Tulin Cil, M.D., F.R.C.S.C.,
Andrew McNaught, M.D., F.R.C.P.C., Jaime M. Escallon, M.D., F.R.C.S.C.,
John L. Semple, M.D., F.R.C.S.C., Wei Wu, M.Sc., Vincent W. Chan, M.D., F.R.C.P.C.
-  Critical Care 2006, 10:R91 (doi:10.1186/cc4939
Sedation in the intensive care unit with remifentanil/propofoL versus midazolam/fentanyl: a randomised, open- label,pharmacoeconomic trial
Bernd Muellejans1, Thomas Matthey1, Joachim Scholpp2 and Markus Schil
-  British Journal of Anaesthesia 104 (5): 538–46 (2010
REVIEWARTICLEFifteen years of ultrasound guidance in regional anaesthesia: Part 1
P. Marhofer1*, W. Harrop-Griffiths2, S. C. Kettner1 and L. Kirchmair3
-  Eur J Anaesthesiol. 2010 Jul;27(7):592-7. doi: 10.1097/EJA.0b013e32833b1adf.
The Helsinki Declaration on Patient Safety in Anaesthesiology.
Mellin-Olsen J1, Staender S, Whitaker DK, Smith AF.
-  ESA newsletter 68 march 2017. http://newsletter.esahq.org/important-and-urgent-issues-in-perioperative- patient-safety-views-of-an-expert-panel/
-  Anesthesiology 2016; 124:1-3
Perioperative Medication Errors Building Safer Systems
Beverley A. Orser, M.D., Ph.D., David U, B.Sc.Phm., M.Sc.Phm.,Michael R. Cohen, M.S., Sc.D. (hon.), D.P.S. (hon.)
-  European Section and Board of Anaesthesiology UEMS
1, October, 2011 EBA UEMS Recommendation for Safe Medication
-  APFS NEWSLETTER The Official Journal of the Anesthesia Patient Safety Foundation www.apsf.org Volume 25, No. 1, 1-20 Circulation 84,122 Spring 2010
-  Anesthesiology, V 124 • No 4 795 April 2016
A Human Factors Engineering Study of the Medication Delivery Process during an Anesthetic
Self-filled Syringes versus Prefilled Syringes
Yushi Yang, Ph.D., Antonia Joy Rivera, Ph.D., Christopher R. Fortier, Pharm.D.,
-  PLOS ONE | DOI:10.1371/journal.pone.0138043 September 18, 2015
RESEARCH ARTICLE Propofol Increases Host Susceptibility toMicrobial Infection by Reducing Subpopulations of Mature Immune Effector Cells at Sites of Infection
-  Anaesthesia 1993; 48: 30–2.
Growth of microorganisms in solutions of intravenous anesthetic agents
Berry CB, Gillespie T, Hood J, Scott NB.
-  Anaesthesia, 2007, 62, pages 575–580
Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space*
T. Fukada1 and M. Ozaki2